Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.160
-0.020 (-0.92%)
Jul 22, 2026, 4:00 PM EDT - Market closed
Aytu BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | -34.06 | -13.56 | -15.84 | -17.05 | -108.78 | -58.29 |
Depreciation & Amortization | 2.81 | 5.38 | 6.73 | 8.82 | 10.15 | 9.2 |
Stock-Based Compensation | 0.66 | 0.58 | 2.37 | 6.05 | 5.25 | 3.57 |
Other Adjustments | 18.92 | 11.41 | 10.02 | 2.86 | 75.43 | 17.87 |
Change in Receivables | 11.34 | -7.63 | 5.2 | -7.15 | 6.53 | 1.54 |
Changes in Inventories | 1.69 | 0.38 | -4.82 | -3.61 | 1.3 | 2.79 |
Changes in Accounts Payable | -1.83 | 0.29 | -2.08 | 2.38 | -7.68 | -3.25 |
Changes in Accrued Expenses | -5.89 | 0.89 | -9.16 | 3.61 | -13.29 | 0.77 |
Changes in Other Operating Activities | -0.28 | 0.34 | 6.2 | -1.03 | 2.28 | -0.18 |
Operating Cash Flow | 1.68 | -1.94 | -1.39 | -5.13 | -28.82 | -25.96 |
Capital Expenditures | -0.03 | -0.23 | -0.33 | - | - | - |
Sale of Property, Plant & Equipment | - | 0.67 | - | - | - | - |
Purchases of Intangible Assets | - | -3 | - | - | - | -2.34 |
Payments for Business Acquisitions | - | - | - | - | - | -15.52 |
Proceeds from Business Divestments | - | - | - | - | - | 15.72 |
Other Investing Activities | - | - | - | -0.12 | -3.25 | -0.64 |
Investing Cash Flow | -3.03 | -2.56 | -0.33 | -0.12 | -3.25 | -2.78 |
Short-Term Debt Issued | 0.38 | 6.67 | 0.83 | -2.25 | - | 51.21 |
Short-Term Debt Repaid | - | - | - | - | -4.12 | -53.98 |
Net Short-Term Debt Issued (Repaid) | 0.38 | 6.67 | 0.83 | -2.25 | -4.12 | -2.77 |
Long-Term Debt Issued | - | 1.86 | 13 | - | 15 | - |
Long-Term Debt Repaid | -1.86 | -1.86 | -15.72 | -0.1 | -16.1 | - |
Net Long-Term Debt Issued (Repaid) | -1.86 | 0 | -2.72 | -0.1 | -1.1 | - |
Issuance of Common Stock | - | 14.84 | 3.47 | 15.58 | 11.69 | 40.15 |
Net Common Stock Issued (Repurchased) | - | 14.84 | 3.47 | 15.58 | 11.69 | 40.15 |
Other Financing Activities | -5.28 | -6.07 | -2.84 | -4.36 | -4.94 | -7.06 |
Financing Cash Flow | 9.9 | 15.44 | -1.26 | 8.87 | 1.53 | 30.31 |
Net Cash Flow | 8.54 | 10.95 | -2.98 | 3.63 | -30.54 | 1.57 |
Free Cash Flow | 1.64 | -2.17 | -1.72 | -5.13 | -28.82 | -25.96 |
FCF Margin | 2.90% | -3.26% | -2.63% | -4.78% | -29.82% | -39.56% |
Free Cash Flow Per Share | 0.14 | -0.34 | -0.31 | -1.54 | -19.61 | -31.01 |
Levered Free Cash Flow | -39.06 | 0.15 | -21.2 | -9.23 | -121.25 | -51.72 |
Unlevered Free Cash Flow | -7.54 | -0.53 | -4.73 | -6.9 | -117.05 | -49.79 |